ANIMAL The Animal Core for the Cancer Center (CC) at the University of Michigan provides a wide range of services to CC members, all of which are related to the care and use of animals in biomedical and cancer research. The goal of the Animal Core and the University of Michigan Unit for Laboratory Animal Medicine (ULAM) is to maintain all animals under specific-pathogen-free status. Maintaining healthy research animal models for CC members is of utmost importance for sustaining animal research and experimental outcomes. Animal housing and husbandry will be provided in dedicated animal facilities by dedicated husbandry technicians and the CC animal facility supervisor. Rodents housed within the CC are maintained in microisolator cages on static or ventilated racks;biohazard housing is available in isolated cubicles. Quarterly rodent health monitoring and surveillance is performed to screen for pathogen status. Additional non-rodent species used by CC members are similarly cared for according to the Guide for the Care and Use of Laboratory Animals. F. Claire Hankenson, DVM, MS, DACLAM, assumed responsibility as Director of the Animal Core in 2004 and continues to serve as Director of the Animal Diagnostic Laboratory (ADL) within ULAM. Robert C. Dysko, DVM, DACLAM, Associate Director of ULAM and former Director of the Animal Core, will oversee the health surveillance program and continue to serve as a consultant to the new Animal Core Director. The Cancer Center members are provided with priority access to veterinary care, with both a designated faculty veterinarian and licensed veterinary technician. Members have access to the ADL, supervised by a certified Medical Technologist, for clinical pathology diagnostics of all species. Specialized equipment for evaluation of rodent-derived specimens is available in the ADL. As well, CC members have priority access to a veterinary pathologist, J. Erby Wilkinson, DVM, PhD, DACVP, for consultation and necropsy and histopathology services. A dedicated necropsy technician and certified histotechnologist are also available to CC members;all necropsy services are to be performed in a renovated state-of-the-art pathology suite maintained within ULAM. These diagnostic services (veterinary, clinical pathology, necropsy, histology and anatomic pathology) are to be offered at no-cost to CC members;as well, members will receive a variable discount on per diem rates calculated annually through ULAM.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA046592-23
Application #
8147785
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2010-06-01
Budget End
2011-05-31
Support Year
23
Fiscal Year
2010
Total Cost
$248,138
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Manohar, Poorni M; Beesley, Lauren J; Bellile, Emily L et al. (2018) Prognostic Value of FDG-PET/CT Metabolic Parameters in Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer. Clin Nucl Med 43:641-647
Hawley, Sarah T; Li, Yun; An, Lawrence C et al. (2018) Improving Breast Cancer Surgical Treatment Decision Making: The iCanDecide Randomized Clinical Trial. J Clin Oncol 36:659-666
Salami, Simpa S; Hovelson, Daniel H; Kaplan, Jeremy B et al. (2018) Transcriptomic heterogeneity in multifocal prostate cancer. JCI Insight 3:
Smith, Joshua; Kulkarni, Aditi; Birkeland, Andrew C et al. (2018) Whole-Exome Sequencing of Sinonasal Small Cell Carcinoma Arising within a Papillary Schneiderian Carcinoma In Situ. Otolaryngol Head Neck Surg 159:859-865
Eberl, Markus; Mangelberger, Doris; Swanson, Jacob B et al. (2018) Tumor Architecture and Notch Signaling Modulate Drug Response in Basal Cell Carcinoma. Cancer Cell 33:229-243.e4
Lazarus, Jenny; Maj, Tomasz; Smith, J Joshua et al. (2018) Spatial and phenotypic immune profiling of metastatic colon cancer. JCI Insight 3:
Kim, Yeung-Hyen; Zhu, Lingqiao; Pyaram, Kalyani et al. (2018) PLZF-expressing CD4 T cells show the characteristics of terminally differentiated effector memory CD4 T cells in humans. Eur J Immunol 48:1255-1257
Davis, Elizabeth J; Griffith, Kent A; Kim, Edward J et al. (2018) A Phase II Study of Biweekly Cisplatin, Fixed-Dose-Rate Gemcitabine and Infusional 5-Fluorouracil in Patients With Metastatic Pancreatic and Biliary Cancers. Am J Clin Oncol 41:128-132
Mendiratta-Lala, Mishal; Masch, William; Shankar, Prasad R et al. (2018) MR Imaging Evaluation of Hepatocellular Carcinoma Treated with Stereotactic Body Radiation Therapy (SBRT): Long Term Imaging Follow-Up. Int J Radiat Oncol Biol Phys :
Tamura, Shuzo; Wang, Yin; Veeneman, Brendan et al. (2018) Molecular Correlates of In Vitro Responses to Dacomitinib and Afatinib in Bladder Cancer. Bladder Cancer 4:77-90

Showing the most recent 10 out of 1493 publications